Ferrazzini G, Maggiorini M, Kriemler S, Bärtsch P, Oelz O
Br Med J (Clin Res Ed). 1987 May 30;294(6584):1380-2. doi: 10.1136/bmj.294.6584.1380.
A double blind, randomised, placebo controlled trial of treatment with dexamethasone for acute mountain sickness was performed in the Capanna "Regina Margherita" at an altitude of 4559 m in the Alps Valais. After 12-16 hours of treatment (8 mg dexamethasone initially, followed by 4 mg every six hours) the mean acute mountain sickness score decreased significantly from 5.4 to 1.3, and eight of 17 patients became totally asymptomatic. Mean arterial oxygen saturation rose from 75.5% to 82.0%, and there was a small increase in standard spirometric measurements. In the placebo group none of these variables changed significantly. It is concluded that dexamethasone may be used as emergency treatment for acute mountain sickness to facilitate safe descent to a lower altitude.
在阿尔卑斯瓦莱州海拔4559米的“玛格丽塔女王”小屋进行了一项关于地塞米松治疗急性高原病的双盲、随机、安慰剂对照试验。治疗12 - 16小时后(初始剂量为8毫克地塞米松,随后每6小时4毫克),急性高原病平均评分从5.4显著降至1.3,17名患者中有8名完全无症状。平均动脉血氧饱和度从75.5%升至82.0%,标准肺功能测量值略有增加。在安慰剂组,这些变量均无显著变化。结论是地塞米松可作为急性高原病的紧急治疗药物,以促进安全下降至较低海拔。